ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials.

By leveraging our team’s 20-year track record of manufacturing more than 100 unique vectors, we are driven to accelerate the development of much-needed therapies so that disease can recede and progress can prevail.

From the design of your vectors to delivery of your gene-modified cells, you can count on us on every step of the journey. A journey that will help bring your innovative ideas to life so that you can make a meaningful difference in the lives of patients everywhere.

Contact ViroCell Biologics Limited
Visit Website